🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
M2951 is an investigational drug under evaluation for treatment of autoimmu...
Status
Terminated
Location
Pinnacle Research Group LLC
Start Date
2017-01-04
Trial ID
NCT02975336
The study was to evaluate the efficacy and safety of evobrutinib administer...
Status
Terminated
Location
Please Contact U.S. Medical Information
Start Date
2019-08-26
Trial ID
NCT04032158
Treatments Being Tested
M2951 is an investigational drug under evaluation for treatment of autoimmu...
Status
Completed
Location
U.S. Medical Information
Start Date
2016-07-31
Trial ID
NCT02784106
The aim of this protocol is to find out about the safety and effectiveness ...
Status
Terminated
Location
Research Site
Start Date
2017-03-07
Trial ID
NCT02975349
Treatments Being Tested
The purpose of this study was to determine the efficacy, dose response, and...
Status
Completed
Location
Arizona Arthritis & Rheumatology Associates, P.C.
Start Date
2017-09-18
Trial ID
NCT03233230
Treatments Being Tested
The primary purpose of this Phase 1b double-blind, randomized, placebo-cont...
Status
Completed
Location
Research site
Start Date
2015-11-30
Trial ID
NCT02537028
Treatments Being Tested
The purpose of this study is to assess potential effects of M2951 on cardia...
Status
Completed
Location
Nuvisan GmbH
Start Date
2022-11-08
Trial ID
NCT07214935
Treatments Being Tested
The study was to evaluate the efficacy and safety of evobrutinib administer...
Status
Terminated
Location
Please Contact U.S. Medical Information
Start Date
2019-09-10
Trial ID
NCT04032171
Treatments Being Tested